Tag Archives: drug

Essential Reads: SBIRT for Women with Alcohol and Drug Use During Pregnancy

Critical to the wellbeing of pregnant women and their infants is universal screening for drug and alcohol use. This is an essential first step in identifying women with harmful substance use and connecting them with appropriate services.  Screening, Brief Intervention and Referral to Treatment or SBIRT has been shown to be a quick and effective… Read More »

Albireo’s rare liver disease drug Bylvay scores back-to-back approvals in U.S., Europe

With a pair of approvals on both sides of the Atlantic, liver disease-focused biotech Albireo is off and running with its new medicine Bylvay. The oral drug, the first treatment for pruritus in patients with progressive familial intrahepatic cholestasis (PFIC), scored an FDA nod Tuesday and a European approval Monday. With the FDA’s blessing, Albireo is kicking off an “immediate”… Read More »

New drug Trodelvy gives hope in fight against deadly triple-negative breast cancer

New drug gives hope in fight against one of the deadliest breast cancers… but will it get the green light in time to save these women? Nicola Tracey was diagnose with triple-negative breast cancer in July 2018 Returned in January and she had to tell her daughters she had months to live Philipa Heatherington was… Read More »

Biogen Alzheimer’s drug and the battle over dementia treatment of the future

Aduhelm by Biogen Source: Biogen The FDA’s approval of Biogen‘s Alzheimer’s drug Aduhelm was a landmark moment in the life of Dr. Paul Aisen. The director of the Alzheimer’s Therapeutic Research Institute at USC has spent the past three decades focused on treating the neurodegenerative disease, and in recent years helped shepherd this particular drug… Read More »

FDA approves Alzheimer’s drug despite controversy over effectiveness

The Food and Drug Administration has approved the Alzheimer’s drug aducanumab despite controversy over whether there is sufficient evidence to support the drug’s effectiveness. Aducanumab is the first Alzheimer’s drug approved by the FDA in almost 20 years. It has been developed by the company Biogen in collaboration with a Japanese firm Eisai. It is… Read More »